Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 1.00 |
| ▸ | PRKCG | P05129 | 5/20 | 1.00 |
| ▸ | PRKCB | P05771 | 5/20 | 1.00 |
| ▸ | PRKCH | P24723 | 5/20 | 1.00 |
| ▸ | PRKCE | Q02156 | 5/20 | 1.00 |
| ▸ | PRKCQ | Q04759 | 5/20 | 1.00 |
| ▸ | PRKCD | Q05655 | 5/20 | 1.00 |
| ▸ | PRKD3 | O94806 | 4/20 | 1.00 |
| ▸ | PRKCI | P41743 | 4/20 | 1.00 |
| ▸ | PRKCZ | Q05513 | 4/20 | 1.00 |
| ▸ | PRKD1 | Q15139 | 4/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3707129 | 1.00 | PRKCA (1.00) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| Phorbol Myristate Acetate SCHEMBL22722418 | 1.00 | PRKCA (1.00) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| Phorbol Myristate Acetate SCHEMBL17368149 | 1.00 | PRKCA (1.00) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| Phorbol Myristate Acetate SCHEMBL18550994 | 1.00 | PRKCA (1.00) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| Phorbol Myristate Acetate SCHEMBL22736719 | 1.00 | PRKCA (1.00) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| Phorbol Myristate Acetate SCHEMBL21165759 | 1.00 | PRKCA (1.00) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL16174732 | 1.00 | PRKCA (1.00) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| Phorbol Myristate Acetate SCHEMBL15423125 | 1.00 | PRKCA (1.00) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| Phorbol Myristate Acetate SCHEMBL19271683 | 1.00 | PRKCA (1.00) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| Phorbol Myristate Acetate SCHEMBL6993831 | 1.00 | PRKCA (1.00) | PRKCAPRKCGPRKCBPRKCHPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11637 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743782-A1 | METHOD FOR DETECTION OF THE POTENTIAL OF A BODY FLUID SAMPLE TO PRODUCE EXTRACELLULAR TRAPS | Belgian Volition SRL (BE) | 2026-05-20 | — | — | EP | claimed |
| CN-122012625-A | Viral vector production | 牛津生物医学（英国）有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4719467-A2 | METHODS OF MANUFACTURING T CELLS | Vittoria Biotherapeutics, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| US-12590293-B2 | Method for obtaining a platelet derived secretome and uses thereof | UNIVERSIDAD DE OVIEDO (ES) | 2026-03-31 | — | — | US | claimed |
| US-12566181-B2 | Methods and compositions for determining the potency of a therapeutic cellular composition | IMMUNOFREE, INC. (US) | 2026-03-03 | — | — | US | claimed |
| US-20260049268-A1 | IN VITRO CELL CULTURE MUCUS SYSTEMS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2026-02-19 | — | — | US | claimed |
| EP-3995139-B1 | COMPOSITION FOR USE IN TREATING CANCER | UNIV GEORGIA STATE RES FOUND (US) | 2026-02-18 | — | — | EP | claimed |
| US-20260041660-A1 | Compositions And Methods for Treating Acute Respiratory Distress Syndrome (ARDS) And Inflammatory Disorders Caused by Corona Viruses and Other Respiratory Pathogens or Agents That Mediate Pulmonary Injury, Inflammation or Acute Respiratory Distress, And Related Compositions and Methods for Treating and Preventing Human SARS Coronavirus Infection, COVID-19 Disease and Related Symptoms | CHANG RICHARD L (US) | 2026-02-12 | — | — | US | claimed |
| US-12539289-B2 | Phorbol ester compositions and methods of use for treating or reducing the duration of cytopenia | BIOSUCCESS BIOTECH COMPANY, LIMITED (US) | 2026-02-03 | — | — | US | claimed |
| EP-4662469-A1 | METHODS OF PREPARING AND FREEZING BIOLOGICAL SAMPLES FOR ANALYTICAL USE AND ASSOCIATED COMPOSITIONS | Allen Institute (US) | 2025-12-17 | — | — | EP | claimed |
| EP-0470604-A2 | PACAP38, proteine with adenylate cyclase activity | Takeda Chemical Industries, Ltd. (JP) | 1992-02-12 | — | — | EP | claimed |
| US-5039794-A | Tumor egress factor and processes for producing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-08-13 | — | — | US | claimed |
| EP-0349127-A1 | Antibody-mediated and ligand-mediated targeting of differentiation-inducers to tumor cells | The Biomembrane Institute (US) | 1990-01-03 | — | — | EP | claimed |
| US-4760021-A | culturing, separating microphase-like cells, activating with mitogen, isolating | DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) | 1988-07-26 | — | — | US | claimed |
| EP-0260708-A2 | Tumor egress factor and processes for producing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1988-03-23 | — | — | EP | claimed |
| US-4613458-A | INHIBITS DNA SYNEHESIS OF T CELLS, AUTOIMMUNE DISEASES | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1986-09-23 | — | — | US | claimed |
| US-4596774-A | Maintaining lymphocytes in medium supplemented with mouse serum while exposing lymphocytes to nitrogen | CENTOCOR, INC. (US) | 1986-06-24 | — | — | US | claimed |
| US-4564593-A | Messenger RNA, production and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1986-01-14 | — | — | US | claimed |
| EP-0135592-A1 | DNA SYNTHESIS-REPRESSING SUBSTANCE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1985-04-03 | — | — | EP | claimed |
| US-4460685-A | Method of enhancing the production of human γ Interferon | NEW YORK UNIVERSITY (US) | 1984-07-17 | — | — | US | claimed |